BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB:HPLF) (FWB:HL1) (WKN:500625) today announced that the Company will present new data from ongoing research and development of its artificial liver device technology at the 6th Annual Meeting of the International Society for Stem Cell Research (ISSCR), June 11-14, 2008. The conference will be held at the Pennsylvania Convention Center in Philadelphia, Pennsylvania.
